Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Long-term Extension Study of PCI-32765 (Ibrutinib)

ClinicalTrials.gov ID: NCT01804686

Public ClinicalTrials.gov record NCT01804686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 25, 2026, 2:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PCI-32765CAN3001: A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.

Study identification

NCT ID
NCT01804686
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
700 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 8, 2013
Primary completion
Dec 30, 2026
Completion
Dec 30, 2029
Last update posted
Jul 30, 2026

2013 – 2029

United States locations

U.S. sites
32
U.S. states
23
U.S. cities
30
Facility City State ZIP Site status
City of Hope Cancer Center Duarte California 91010 Completed
University of California San Diego Medical Center La Jolla California 92093 Completed
University of California Los Angeles Los Angeles California 90095 Completed
St. Joseph Hospital Center for Cancer Prevention and Treatment Orange California 92868 Recruiting
Stanford University Medical Center Stanford California 94305 Completed
Stanford University Stanford California 94305 Completed
Norwalk Medical Group Norwalk Connecticut 06850 Completed
Northwest Georgia Oncology Centers PC Marietta Georgia 30060 Completed
Northwestern University Hospital Chicago Illinois 60611 Completed
Indiana University Goshen Indiana 46526 Completed
Kansas University Medical Center Westwood Kansas 66205 Completed
Louisville Oncology Suburban - Norton Cancer Institute Louisville Kentucky 40207 Completed
Dana Farber Cancer Center Boston Massachusetts 02215 Completed
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 Completed
Battle Creek Health Systm Battle Creek Michigan 49016 Completed
Karmanos Cancer Institute - Wayne State University Detroit Michigan 48201 Completed
Washington University St Louis Missouri 63110 Completed
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 Completed
Hackensack University Medical Center Hackensack New Jersey 07601 Completed
Weill Medical College of Cornell University New York New York 10021 Completed
Memorial Sloan-Kettering Cancer Center New York New York 10065 Completed
Southeastern Medical Oncology Center Goldsboro North Carolina 27534 Completed
The Ohio State University- James Cancer Hospital Columbus Ohio 43210 Recruiting
Willamette Valley Cancer Center Eugene Oregon 97401 Recruiting
Kaiser Permanente Portland Oregon 97227 Completed
University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104 Completed
Avera Medical Group Sioux Falls South Dakota 57105 Recruiting
MD Anderson Cancer Center - University of Texas Houston Texas 77030 Completed
University of Virginia Charlottesville Virginia 22908 Completed
University of Washington Seattle Washington 98109 Completed
West Virginia University Morgantown West Virginia 26506 Completed
University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research Madison Wisconsin 53705 Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 143 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01804686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01804686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →